Walgreens Boots Alliance, Inc. (WBA)
- Previous Close
17.60 - Open
17.52 - Bid 17.70 x 100
- Ask 17.72 x 2900
- Day's Range
17.49 - 17.95 - 52 Week Range
17.49 - 35.36 - Volume
6,410,890 - Avg. Volume
12,687,579 - Market Cap (intraday)
15.27B - Beta (5Y Monthly) 0.75
- PE Ratio (TTM)
-- - EPS (TTM)
-7.00 - Earnings Date Jun 25, 2024 - Jul 1, 2024
- Forward Dividend & Yield 1.00 (5.65%)
- Ex-Dividend Date May 20, 2024
- 1y Target Est
21.17
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
www.walgreensbootsalliance.com330,000
Full Time Employees
August 31
Fiscal Year Ends
Sector
Industry
Recent News: WBA
Performance Overview: WBA
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: WBA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: WBA
Valuation Measures
Market Cap
15.27B
Enterprise Value
48.23B
Trailing P/E
--
Forward P/E
5.81
PEG Ratio (5yr expected)
2.14
Price/Sales (ttm)
0.11
Price/Book (mrq)
1.13
Enterprise Value/Revenue
0.33
Enterprise Value/EBITDA
-4.29
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.18%
Return on Assets (ttm)
1.12%
Return on Equity (ttm)
-57.19%
Revenue (ttm)
144.6B
Net Income Avi to Common (ttm)
-6.04B
Diluted EPS (ttm)
-7.00
Balance Sheet and Cash Flow
Total Cash (mrq)
676M
Total Debt/Equity (mrq)
225.38%
Levered Free Cash Flow (ttm)
334.88M
Research Analysis: WBA
Company Insights: WBA
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: WBA
Analyst Report: Walgreens Boots Alliance Inc
Walgreens Boots Alliance Inc. based in Deerfield, Illinois, is a holding company created in December 2014 when Walgreen completed its purchase of privately held Alliance Boots. The company generated $139 billion in FY23 sales. After divesting its healthcare distribution business WBA has presence in more than 9 countries. About 85% of revenue is from the United States. The company has over 14,000 stores under the Walgreen, Duane Reade and Boots names. WBA owns about 16% of Cencora. WBA's fiscal year ends on August 31. The company has reclassified its operations again. The new organization has a United States Retail Pharmacy unit, an International unit, and a U.S. Healthcare segment, which includes recent investments in VillageMD, CareCentrix and Shields Health Solutions.
RatingPrice TargetMarket Update: COF, HBAN, JBLU, SKX, UNP, URI, WBA
U.S. stocks rose on Friday morning following PCE data. The Fed's preferred inflation indicator, the personal consumption expenditures index (PCE), rose 0.3% in March, which was below estimates of a 0.5% increase and matched the increase in February. Core PCE also rose 0.3%, which was steady from last month and in line with estimates. The latest readings bring the annual rate for headline PCE to 2.7%, up from 2.5% in February, and core PCE to 2.8%, which was unchanged from last month. The Dow was down 0.4%, the S&P 500 fell 1.1% and the Nasdaq lost 2.1%. Crude oil is trading near $84 per barrel and gold is up $5 to $2348 per ounce.
Daily – Vickers Top Buyers & Sellers for 04/03/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Analyst Report: Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance is one of the largest retail pharmacy chains in the U.S., with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the U.S. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
RatingPrice Target